Quest Diagnostics Inc
NYSE:DGX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
123.78
163.89
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Quest Diagnostics Inc
Quest Diagnostics Inc
Change in Working Capital
Quest Diagnostics Inc
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Change in Working Capital
-$60m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
16%
|
|
|
DaVita Inc
NYSE:DVA
|
Change in Working Capital
-$80.4m
|
CAGR 3-Years
29%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Change in Working Capital
-$138.7B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-25%
|
|
|
Cigna Corp
NYSE:CI
|
Change in Working Capital
-$2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-18%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Change in Working Capital
-$259.2m
|
CAGR 3-Years
22%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
|
|
R1 RCM Inc
NASDAQ:RCM
|
Change in Working Capital
-$59.8m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Quest Diagnostics Inc
Glance View
In the rapidly evolving world of healthcare, Quest Diagnostics Inc. stands as a pivotal player, shaping the future of diagnostic services. Born out of a quest for innovation in clinical testing, Quest Diagnostics operates at the intersection of medical science and cutting-edge technology. The company has a wide-reaching network of laboratories and service centers, offering a comprehensive array of diagnostic testing solutions that range from routine blood tests to advanced genetic screening. Their services are not limited to hospitals and physician offices; they extend into a variety of sectors including pharmaceuticals, food, and global business services, completing over a hundred million clinical laboratory tests annually. Quest's robust infrastructure and commitment to precision ensure that patients and healthcare providers receive timely and accurate information that is crucial for early detection, diagnosis, and informed treatment decisions. Quest Diagnostics' revenue model is straightforward yet effective, driven primarily by service fees from its expansive menu of tests. By collaborating with insurers, healthcare providers, and employers, Quest ensures broad access to its services. Moreover, the company continually invests in research and development to expand its test portfolio and enhance the quality of its services, thus staying competitive in the fast-paced healthcare environment. Through strategic acquisitions and partnerships, Quest has broadened its geographical reach and bolstered its technological capabilities, maintaining its position as an industry leader. As healthcare increasingly leans toward personalized medicine and preventive care, Quest Diagnostics is poised to leverage its analytical prowess and deep repository of health data to drive future growth and innovation, serving as an indispensable ally in global public health.
See Also
What is Quest Diagnostics Inc's Change in Working Capital?
Change in Working Capital
-60m
USD
Based on the financial report for Sep 30, 2024, Quest Diagnostics Inc's Change in Working Capital amounts to -60m USD.
What is Quest Diagnostics Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
16%
Over the last year, the Change in Working Capital growth was 73%. The average annual Change in Working Capital growth rates for Quest Diagnostics Inc have been 12% over the past three years , and 16% over the past ten years .
You don't have any saved screeners yet